Inventor · disambiguated record
Stepan Chuprakov
Also filed as: Chuprakov Stepan
7 granted patents·11 pending applications·1 citations·filing 2017–2024
72Inventor score
Top patents by PatentIndex Score
18 records- 0180US11376334B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2020·Granted Jul 5, 2022·1 cites·16 claims
- 0276US2025223302A1Camptothecine antibody-drug conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 0374US12187745B2Camptothecine antibody-drug conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Granted Jan 7, 2025·0 cites·15 claims
- 0474US2024342303A1Sulfatase-Cleavable Linkers for Antibody-Drug ConjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 0571US2025179117A1Glycoside dual-cleavage linkers for antibody-drug conjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 0670US11564989B2Camptothecine antibody-drug conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Granted Jan 31, 2023·0 cites·17 claims
- 0767US11980668B2Sulfatase-cleavable linkers for antibody-drug conjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2019·Granted May 14, 2024·0 cites·15 claims
- 0866US2025101098A1Antibodies and antibody conjugates specific for nectin-4 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 0965US2025121083A1Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) Antibody-Maytansine Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1064US2025121090A1Antibody-Drug Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1162US10758628B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Sep 1, 2020·0 cites·15 claims
- 1261US12187810B2Glycoside dual-cleavage linkers for antibody-drug conjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted Jan 7, 2025·0 cites·15 claims
- 1360US2025295803A15t4 antibody-drug conjugates and uses thereofEXELIXIS INC·Filed 2023·Application pending·0 cites
- 1459US2025152724A1Antibody conjugates specific for mucin-1 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1558US2024343818A1Antibodies Having Humanized Framework RegionsSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1657US10195283B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2017·Granted Feb 5, 2019·0 cites·17 claims
- 1754US2024148883A1Branched Linkers for Antibody-Drug Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1853US2024197907A1Dual-Cleavage Ester Linkers for Antibody-Drug ConjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stepan Chuprakov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →